These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 15669893
1. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. Fava M, Thase ME, DeBattista C. J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893 [Abstract] [Full Text] [Related]
2. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. Thase ME, Fava M, DeBattista C, Arora S, Hughes RJ. CNS Spectr; 2006 Feb; 11(2):93-102. PubMed ID: 16520686 [Abstract] [Full Text] [Related]
4. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. Ninan PT, Hassman HA, Glass SJ, McManus FC. J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082 [Abstract] [Full Text] [Related]
5. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. Dunlop BW, Crits-Christoph P, Evans DL, Hirschowitz J, Solvason HB, Rickels K, Garlow SJ, Gallop RJ, Ninan PT. J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129 [Abstract] [Full Text] [Related]
6. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ. Ann Clin Psychiatry; 2007 Dec; 19(3):153-9. PubMed ID: 17729016 [Abstract] [Full Text] [Related]
7. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. Schwartz TL, Azhar N, Cole K, Hopkins G, Nihalani N, Simionescu M, Husain J, Jones N. J Clin Psychiatry; 2004 Sep; 65(9):1223-7. PubMed ID: 15367049 [Abstract] [Full Text] [Related]
14. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M. J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620 [Abstract] [Full Text] [Related]
18. Symptoms of fatigue and sleepiness in major depressive disorder. Baldwin DS, Papakostas GI. J Clin Psychiatry; 2006 Aug; 67 Suppl 6():9-15. PubMed ID: 16848671 [Abstract] [Full Text] [Related]
19. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial. Rickels K, Athanasiou M, Robinson DS, Gibertini M, Whalen H, Reed CR. J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933 [Abstract] [Full Text] [Related]
20. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. Feighner JP, Overø K. J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628 [Abstract] [Full Text] [Related] Page: [Next] [New Search]